Cipla Arm to Procure Solar Power from AMPIN Energy Transition in Maharashtra
Jay Precision Pharmaceuticals, a Cipla subsidiary, will source solar power from AMPIN Energy Transition. The company has signed a Share Purchase, Subscription and Shareholder’s Agreement to acquire a 26 percent stake in SPV – AMPIN Energy C&I Eighteen at a cost of about INR 1.46 crore. It will set up a captive solar power project in Maharashtra.
May 21, 2025. By Mrinmoy Dey
The company has entered into a Share Purchase, Subscription and Shareholder’s Agreement (SPSSA) to acquire a 26 percent stake on a fully diluted basis in Ampin’s special purpose vehicle (SPV) – AMPIN Energy C&I Eighteen at a cost of about INR 1.46 crore.
“This is in line with the commitment to enhance the share of renewable power sources in its operation and to comply with regulatory requirements for being a ‘captive user’ under Indian electricity laws,” Cipla stated in a regulatory filing.
The SPV will be setting up a captive solar power project in Maharashtra.
Cipla is continuously increasing its renewable energy intake. In February 2022, Cipla entered into an SPSSA with AMPIN Energy Transition to procure solar power from the latter’s 10 MWac (16 MWdc) captive open access solar project in Osmanabad.
In January 2021, Cipla had announced that it would procure solar power from a 20 MWac group captive project of AMPIN in Tuljapur, Maharashtra. This project will supply power to Cipla's manufacturing units at Kurkumbh and Patalganga in Maharashtra.
In May 2019, Cipla had acquired a 26 percent stake in AMP Solar Power System, a wholly-owned subsidiary of AMP Solar Technology, and a special purpose vehicle formed to set up the captive solar project.
In the recent past, pharmaceutical companies have increased their RE intake. In April 2025, AMPIN Energy Transition signed a 9.9 MWp solar power PPA with Poly Medicure, supporting the company's sustainability goals by supplying solar energy to five plants in Faridabad from its 75 MWp solar park in Sirsa, Haryana.
In March 2025, Supriya Lifescience inaugurated a state-of-the-art (SOTA) 5 MWp solar power facility in Nanded District, Maharashtra.
In February 2025, Hyderabad-based Aurobindo Pharma signed a power purchase agreement with Swarnaaskshu Solar Power to procure solar energy under a captive arrangement. It will be investing up to INR 10.40 crore for a 26 percent stake in the company's planned 30 MW AC (40 MW DC) solar plant in Telangana.
In February 2025, Mumbai-based Aarti Drugs partnered with Prozeal Green Energy to procure solar power through a captive arrangement. The company picked up a 26.25 percent stake in an SPV for INR 8.05 crore to develop a 24.40 MWp solar power plant.
In January 2025, Ahmedabad-based pharmaceutical company Concord Biotech announced that it will procure 9.9 MW wind-solar hybrid power from Clean Max Enviro Energy Solutions (CleanMax) for its manufacturing plant located at Dholka, Gujarat, through a captive arrangement.
In October 2024, Bengaluru-based Strides Pharma invested INR 1.61 crore for a 2.48 percent stake in AMPIN Energy C&I One to procure solar power for its Chennai facility via a group captive arrangement.
AMPIN Energy Transition has a total portfolio of about 5 GWp spread across 22 states in the country. It possesses a balanced portfolio of renewable energy assets using a blend of solar, wind and storage to provide green power to utility and commercial and industrial (C&I) customers.
please contact: contact@energetica-india.net.
Jameson Mendonca
Power Generation Business Leader
Cummins India’s Jameson Mendonca on Innovations in Gensets, Green Fuel, and Emission Compliance
Shilpy Dewan
VP – Markets, Operations & Digital
Digital Innovation and Storage will Drive India’s Green Future: Serentica’s Shilpy Dewan
Er. Neha Sakka
Electrical Engineer
She Matters: Women Remain Severely Underrepresented in EV and Green Workforces
Satish Talmale
CEO
India is Well-placed to Become a Global Leader in Energy Storage: EnerGrid CEO Satish Talmale
Anand Sri Ganesh, CEO, NSRCEL
Sapna Bhawnani
Alstom and NSRCEL on Empowering the Green Mobility Disruptors